CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Aug 2

PMID 34336660

Citations 80

Authors

Gurcan Gunaydin

Affiliations

Soon will be listed here.

Abstract

Cancer associated fibroblasts (CAFs) and tumor associated macrophages (TAMs) are among the most important and abundant players of the tumor microenvironment. CAFs as well as TAMs are known to play pivotal supportive roles in tumor growth and progression. The number of CAF or TAM cells is mostly correlated with poor prognosis. Both CAFs and TAMs are in a reciprocal communication with the tumor cells in the tumor . In addition to such interactions, CAFs and TAMs are also involved in a dynamic and reciprocal interrelationship with each other. Both CAFs and TAMs are capable of altering each other's functions. Here, the current understanding of the distinct mechanisms about the complex interplay between CAFs and TAMs are summarized. In addition, the consequences of such a mutual relationship especially for tumor progression and tumor immune evasion are highlighted, focusing on the synergistic pleiotropic effects. CAFs and TAMs are crucial components of the tumor microenvironment; thus, they may prove to be potential therapeutic targets. A better understanding of the tri-directional interactions of CAFs, TAMs and cancer cells in terms of tumor progression will pave the way for the identification of novel theranostic cues in order to better target the crucial mechanisms of carcinogenesis.

Citing Articles

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P Cancers (Basel). 2025; 17(5).

PMID: 40075679 PMC: 11899103. DOI: 10.3390/cancers17050832.

LOX iCAFs in HNSCC have the potential to predict prognosis and immunotherapy responses revealed by single cell RNA sequencing analysis.

Liu X, Li H, Wang Y, Zhang Q, Liu Y, Liu T Sci Rep. 2025; 15(1):7028.

PMID: 40016474 PMC: 11868481. DOI: 10.1038/s41598-025-91036-6.

Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data.

Tan J, Le H, Deng J, Liu Y, Hao Y, Hollenberg M Nat Biomed Eng. 2025; .

PMID: 39979589 DOI: 10.1038/s41551-025-01348-1.

Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells.

Cheng Y, Chen M, Yadav V, Pikatan N, Fong I, Kuo K Transl Oncol. 2025; 53:102274.

PMID: 39823981 PMC: 11787020. DOI: 10.1016/j.tranon.2025.102274.

The role of adipogenic niche resident cells in colorectal cancer progression in relation to obesity.

Domagalski M, Olszanska J, Pietraszek-Gremplewicz K, Nowak D Obes Rev. 2025; 26(4):e13873.

PMID: 39763022 PMC: 11884973. DOI: 10.1111/obr.13873.

References

Allaoui R, Bergenfelz C, Mohlin S, Hagerling C, Salari K, Werb Z . Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016; 7:13050. PMC: 5062608. DOI: 10.1038/ncomms13050. View

Shapcott M, Hewitt K, Rajpoot N . Deep Learning With Sampling in Colon Cancer Histology. Front Bioeng Biotechnol. 2019; 7:52. PMC: 6445856. DOI: 10.3389/fbioe.2019.00052. View

Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View

Wu K, Lin K, Li X, Yuan X, Xu P, Ni P . Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. Front Immunol. 2020; 11:1731. PMC: 7417513. DOI: 10.3389/fimmu.2020.01731. View

Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z . Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019; 26(1):78. PMC: 6800990. DOI: 10.1186/s12929-019-0568-z. View

Tham M, Khoo K, Pin Yeo K, Kato M, Prevost-Blondel A, Angeli V . Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma. Oncotarget. 2015; 6(26):22857-68. PMC: 4673204. DOI: 10.18632/oncotarget.3127. View

Welters M, Santegoets S, van der Burg S . The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma. Front Oncol. 2021; 10:545385. PMC: 7793705. DOI: 10.3389/fonc.2020.545385. View

Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L . Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017; 36(31):4457-4468. PMC: 5507301. DOI: 10.1038/onc.2017.65. View

Zeisberg E, Potenta S, Xie L, Zeisberg M, Kalluri R . Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007; 67(21):10123-8. DOI: 10.1158/0008-5472.CAN-07-3127. View

10.

Gonzalez-Gonzalez L, Alonso J . Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression. Front Oncol. 2018; 8:225. PMC: 6005831. DOI: 10.3389/fonc.2018.00225. View

11.

Comito G, Giannoni E, Segura C, Barcellos-de-Souza P, Raspollini M, Baroni G . Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2013; 33(19):2423-31. DOI: 10.1038/onc.2013.191. View

12.

Dimanche-Boitrel M, Vakaet Jr L, Pujuguet P, Chauffert B, Martin M, Hammann A . In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer. 1994; 56(4):512-21. DOI: 10.1002/ijc.2910560410. View

13.

Winograd R, Byrne K, Evans R, Odorizzi P, Meyer A, Bajor D . Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer Immunol Res. 2015; 3(4):399-411. PMC: 4390506. DOI: 10.1158/2326-6066.CIR-14-0215. View

14.

An Y, Liu F, Chen Y, Yang Q . Crosstalk between cancer-associated fibroblasts and immune cells in cancer. J Cell Mol Med. 2019; 24(1):13-24. PMC: 6933413. DOI: 10.1111/jcmm.14745. View

15.

Hong L, Sun H, Lv X, Yang D, Zhang J, Shi Y . Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep. 2009; 37(5):2285-93. DOI: 10.1007/s11033-009-9721-1. View

16.

LeBleu V, Taduri G, OConnell J, Teng Y, Cooke V, Woda C . Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19(8):1047-53. PMC: 4067127. DOI: 10.1038/nm.3218. View

17.

Hasko G, Pacher P . Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol. 2012; 32(4):865-9. PMC: 3387535. DOI: 10.1161/ATVBAHA.111.226852. View

18.

Nakasone E, Askautrud H, Kees T, Park J, Plaks V, Ewald A . Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012; 21(4):488-503. PMC: 3332002. DOI: 10.1016/j.ccr.2012.02.017. View

19.

Kitamura H, Ohno Y, Toyoshima Y, Ohtake J, Homma S, Kawamura H . Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci. 2017; 108(10):1947-1952. PMC: 5623748. DOI: 10.1111/cas.13332. View

20.

Sun W, Fu S . Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer. Oncol Lett. 2019; 18(3):2173-2178. PMC: 6676664. DOI: 10.3892/ol.2019.10587. View